Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,856 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Standardization of allergen products: 3. Validation of candidate European Pharmacopoeia standard methods for quantification of major birch allergen Bet v 1.
Kaul S, Zimmer J, Dehus O, Costanzo A, Daas A, Buchheit KH, Asturias JA, Barber D, Carnés J, Chapman M, Dayan-Kenigsberg J, Döring S, Führer F, Hanschmann KM, Holzhauser T, Ledesma A, Moingeon P, Nony E, Pini C, Plunkett G, Reese G, Sandberg E, Sander I, Strecker D, Valerio C, van Ree R, Vieths S. Kaul S, et al. Allergy. 2016 Oct;71(10):1414-24. doi: 10.1111/all.12898. Epub 2016 Apr 28. Allergy. 2016. PMID: 27018782
BSP090--the follow-up to CREATE.
Neske F, Schörner C, Buchheit KH, Costanzo A, Hanschmann KM, Himly M, Holzhauser T, Ferreira F, Kaul S, Vieths S, van Ree R. Neske F, et al. Among authors: kaul s. Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess. 2009;96:12-9; discussion 19-20. Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess. 2009. PMID: 20799441 No abstract available.
Regulation, role and future of named patient products in Germany.
May S, Kaul S, Lüttkopf D, Vieths S. May S, et al. Among authors: kaul s. Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess. 2009;96:193-7; discussion 197-9. Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess. 2009. PMID: 20799461 No abstract available.
Regulatory aspects of specific immunotherapy in Europe.
Kaul S, Englert L, May S, Vieths S. Kaul S, et al. Curr Opin Allergy Clin Immunol. 2010 Dec;10(6):594-602. doi: 10.1097/ACI.0b013e32833fd5d2. Curr Opin Allergy Clin Immunol. 2010. PMID: 20864886 Review.
1,856 results